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An ethanol extract of Chinese propolis (EECP) was given intraperitoneally to rats suﬀering from hemitransection of half of their
spinal cord (left side) at the level of the 10th thoracic vertebra to examine the eﬀects of the EECP on the functional recovery
of locomotor activity and expression of mRNAs of inducible nitric oxide (NO) synthase (iNOS) and neurotrophic factors in
the injury site. Daily administration of EECP after the spinal cord injury ameliorated the locomotor function, which eﬀect was
accompaniedbyareducedlesionsize.Furthermore,theEECPsuppressediNOSgeneexpression,thusreducingNOgeneration,and
also increased the expression level of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the lesion site, suggesting
that the EECP reduced the inﬂammatory and apoptotic circumstances through attenuation of iNOS mRNA expression and
facilitation of mRNA expression of neurotrophins in the injured spinal cord. These results suggest that Chinese propolis may
become a promising tool for wide use in the nervous system for reducing the secondary neuronal damage following primary
physical injury.
1.Introduction
Propolis is a natural substance collected by honeybees from
buds and exudates of certain trees and plants, and is used in
the beehive as a protective barrier against enemies. Propolis,
which has been used in folk medicines in many regions
of the world for centuries [1], is reported to contain over
300 compounds including alcohols, aldehydes, aromatic
acids and esters, ﬂavonoids, fatty acids, terpenoids, steroids,
and carbohydrates [2–4]. As some of these compounds
exert antioxidant [5], antibacterial [6], antiviral [7], anti-
inﬂammatory [8], and anticancer [9] activities, propolis is
extensively used in foods and beverages to maintain health
and to prevent or lessen the severity of diseases such as
inﬂammation, heart disease, diabetes, and cancer [2, 10].
Bee products are useful tools to protect against and to
provide therapy for some particular neurological disorders
[11]. With regard to the eﬀects of propolis on the nervous
system, evidence showing that propolis and/or its compo-
nents are neuroprotective against various brain insults in
vivo or neuronal damage in vitro has been rapidly accu-
mulating. For instance, caﬀeic acid phenethyl ester (CAPE,
[12–14],) pinocembrin [15], and water-soluble components
of propolis [16] are neuroprotective against excitotoxic
insults in ischemia/reperfusion injury. Furthermore, water-
solublecomponentsofpropoliscanamelioratescopolamine-
inducedlearningandmemoryimpairmentinmice[17];they
playaprotectiveroleagainstoxidativestress-induceddamage
to the retina [18]. Although these protective activities may
be partially due to radical-scavenging actions, the regulation
of signal transduction, such as inhibition of NFκBa n d
activationofc-JunN-terminalkinase,isalsopostulatedtobe
involved [19]. Thus, many reports indicate that propolis and
its constituents protect against neuronal death at least partly
by the mediation of their antioxidant activity. However, little
is known about the eﬀects of propolis on neurite outgrowth
or axonal regeneration except for a recent ﬁnding showing
that one of the major components of Brazilian propolis,
artepillin C, stimulates neurite outgrowth from cultured rat
pheochromocytoma PC12 cells [20].
That a regenerative response is critically limited in the
central nervous system of mammals is a serious problem,
although many experimental strategies have been employed
to minimize tissue damage and to enhance axonal growth
andregeneration.Inthecaseofaspinalcordinjury(SCI),the
failure of axonal regeneration is thought to result partly from
the expression of axonal growth-inhibiting molecules [21],
the lack of neurotrophic factors [22], and/or inﬂammatory2 Evidence-Based Complementary and Alternative Medicine
reactions [23]. Among these possibilities, inﬂammation is
a response that occurs immediately after SCI, and is likely
to cause secondary injury that magniﬁes the primary injury
and facilitates neuronal dysfunction. In the CNS, nitric oxide
(NO)playsimportantrolesundernormalcircumstancesand
also seems to be involved in the pathophysiology observed
under ischemic and traumatic conditions [24, 25]. NO
is increased in the injured site after SCI; and the NO-
induced might be neurotoxic [26], which is consistent with
a ﬁnding that NO is closely involved in the development of
pathological processes in vivo such as posttraumatic spinal
cord cavitation [27].
Therefore, we evaluated the eﬀect of an ethanol extract
of Chinese propolis (EECP), because many biologically
activeconstituents[28],including neuroprotective ones such
as pinocembrin [29], are in abundance in the methanol
or ethanol extract of this substance. EECP was given
intraperitoneally to rats, and the expression of mRNAs of
iNOS and neurotrophic factors in the injury site and the
eﬀect on functional recovery after SCI were examined. We
found a novel conspicuous activity of EECP that suppressed
iNOS gene expression, thus reducing NO generation, and
increased the expression level of brain-derived neurotrophic
factor (BDNF) and neurotrophin-3 (NT-3) mRNAs in the
lesion site. In addition, EECP ameliorated the locomotor
activity after SCI, which improvement was accompanied by
a reduced lesion size in the injury site.
These results suggest that Chinese propolis may become
a promising tool for wide use in the nervous system
for reducing the secondary neuronal damage following a
primary physical injury.
2.SubjectsandMethods
2.1. Animal Surgery. Female Wistar rats (7 weeks of age,
weighing 120–140g; Japan SLC, Hamamatsu, Japan) were
used in this study, and were handled in accordance with
the Guidelines of Experimental Animal Care issued by the
Oﬃce of the Prime Minister of Japan. The animals were
anesthetized with sodium pentobarbital (40mg/kg body
weight), and the half of the spinal cord (left side) was
hemitransected by microsurgical scissors after laminectomy
at the level of the 10th thoracic vertebra. After arrest of
hemorrhage,themuscleandskinweresutured.Theratswere
thenplacedin normalcagesandgiven freeaccesstofood and
water.
2.2. Administration of EECP. Chinese propolis was collected
in the Shangdong Province of China from July to August. It
was extracted with 95% ethanol while being stirred for 24
hoursatroomtemperaturetoyieldtheEECP.TheEECPthus
prepared was a generous gift from Api Co., Ltd., Gifu, Japan.
It was diluted with sterile phosphate-buﬀered saline (PBS)
and intraperitoneally administered to the animals (0.2, 1 or
5mg/kg)immediatelyaftertheinjuryandthenonceevery24
hours for 3 weeks. The vehicle-treated animals received PBS-
containing ethanol whose ﬁnal concentration was equal to
that of the EECP solution.
2.3. Assessment of Locomotor Function. Locomotor function
of the left hindlimb in which neural transmission had been
halted ipsilaterally was assessed by the Basso, Beattie, and
Bresnahan (BBB) locomotor scale in openﬁeld as described
earlier [30]. Evaluation was performed once a day for 3
weeks immediately after the SCI by observers blinded to the
experimental treatments.
2.4. Reverse Transcription-Polymerase Chain Reaction (RT-
PCR). For the RT-PCR experiment, the spinal cords of rats
that had received daily administration of vehicle or EECP
were dissected out immediately after the hemitransection
or 1, 3, 7, or 14 days later; and the segments just rostral
or caudal to the injury site (2-mm length for each) were
collected. Total RNA was isolated from the collected spinal
cords by using TRIZOL Reagent (Invitrogen) according
to the manufacturer’s instruction. All RNA samples were
treated with DNase I to remove contaminating genomic
DNA. RT-PCR was performed as described previously in
[31] to assess the mRNA levels of iNOS, BDNF, NT-3,
and glial cell line-derived neurotrophic factor (GDNF). β-
Actin was used as the internal control. The ampliﬁca-
tion was carried out with a thermal cycler at 94
◦Cf o r
5 minutes, followed by 24–38 cycles consisting of 94
◦C
for 30second, 60–63
◦Cf o r1m i n u t e ,a n d7 2
◦Cf o r4 5
second. The sequences of primers, annealing temperature,
and size of PCR product were as follow: for the β-actin
forward primer, 5 -GCCGTCTTCCCCTCCATCGT-3 ,a n d
reverse primer, 5 -CCCGTCTCCGGAGTCCATCA-3 ,a t
63
◦C (390bp); for the iNOS forward primer, 5 -GCT-
GGAGGTGACCATGGAGCAT-3 ,a n dr e v e r s ep r i m e r ,5  -
CCTGGCTAGCGCTTCCGACTTT-3 ,a t6 3
◦C (688bp);
for the BDNF forward primer, 5 -CCCAGGGCAGGT-
TCGAGAGG-3 ,a n dr e v e r s ep r i m e r ,5  -CCCGCCAGA-
CATGTCCACTG-3 ,a t6 1
◦C (350bp); for the NT-3 for-
ward primer, 5 -TTACCAGAGCACCCTGCCCAAA-3 ,a n d
reverse primer, 5 -ACCTGGTGTCCCCGAATGTCAA-3 ,
at 61
◦C (348bp); and for the GDNF forward primer, 5 -
GAGAGGAATCGGCAGGCTGCAGCTG-3 ,a n dr e v e r s e
primer, 5 -CAGATACATCCACATCGTTTAGCGG-3 ,a t
60
◦C (337bp). After ampliﬁcation, PCR products were
subjected to 2% agarose gel electrophoresis and visualized by
ethidium bromide staining. The images were captured with
FLA-5100 (FUJIFILM, Tokyo, Japan). The optical density of
eachbandwasquantiﬁedbyutilizingimage-analysissoftware
(NIH ImageJ).
2.5. Tissue Preparation for Immunohistochemical Analysis.
The animals were deeply anesthetized by an intraperitoneal
injection of sodium pentobarbital and then cardio-perfused
with 4% paraformaldehyde (PFA) in 0.1M phosphate buﬀer
(pH 7.4). The spinal cord tissues including the lesion
site were dissected out and postﬁxed in the same ﬁxative
overnight at 4◦C. The tissues were then soaked in cold
PBS containing 20% sucrose for 15hours, and subsequently
frozen in embedding compound (Sakura Finetek, Tokyo,
Japan). Frozen sections (30-μm thickness) were prepared
with a cryostat (model CM 1800; Leica, Nussloch, Germany)Evidence-Based Complementary and Alternative Medicine 3
and placed on adhesive-coated slides (Matsunami, Osaka,
Japan).
2.6. Immunohistochemical Analysis. Cryostat sections were
ﬁxed with 4% PFA solution for 10 minutes at 37
◦Ca n d
rinsed for 30minutes at 37
◦C in 0.1M Tris-HCl buﬀer (pH
7.4) containing 0.3% (v/v) Triton X-100. After having been
washed with PBS, the sections were blocked for 30min at
room temperature in PBS containing 2% Block Ace and then
reacted with the diluted primary antibody speciﬁc for glial
ﬁbrillary acidic protein (GFAP; 1:1000, Dakocytomation,
Glostrup, Denmark) for appropriate times at 4◦C. After
another wash with PBS, the sections were incubated with
ﬂuorescence-conjugated secondary antibody for 3 hours at
room temperature (Alexa 546-conjugated goat anti-rabbit
IgG; 1:1000, purchased from Invitrogen, Carlsbad, CA).
The slides were washed with PBS and coverslipped with
PermaFluor Aqueous Mounting Medium (Thermoshandon,
Waltham, CA). Finally, the images were observed with a
confocal laser microscope (LSM 510; Zeiss).
2.7. Image Analysis. Lesion size of the injury site was
measured by tracing the lesion area within the borders of the
lesions as deﬁned by GFAP labeling through 5 representative
horizontal sections, the positions being 0.12 and 0.24mm
ventral to the midline, at the midline, and 0.12 and 0.24mm
dorsal to the midline in each rat.
2.8. Statistical Analysis. All numerical data were presented
as group mean values with standard error (SE). Statistical
analysis of locomotor function assessed by using the BBB
scale and that of various gene expressions in the injured
spinal cord were performed by two-way analysis of variance
(ANOVA) followed by the Bonferroni posttest. A statistically
signiﬁcant diﬀerence in the size of the lesion site was
determined by performing Student’s t-test.
3. Results
3.1. Locomotor Recovery of SCI Rats with EECP Treatment.
We evaluatedthe eﬀectofvarious doses ofEECP on theloco-
motor activity of the left hindlimb of hemi-transected rats
for over 3 weeks after the SCI by using the BBB rating scale.
Hemi-transection of the spinal cord resulted in complete
paralysis of the hindlimb ipsilateral to the transection side
(left)forseveraldaysinallgroups.Afterwards,thelocomotor
function was restored rapidly, and attained a plateau value
(11-12 points) of the BBB rating scale by 3 weeks after the
injury in the vehicle-treated group (Figure 1). The animals
that had received a low dose of EECP (0.2mg/kg) did
not show any additional improvement throughout the test
period (Figure 1(a)) whereas signiﬁcantly more rapid and
higher improvement of locomotor function was observed in
the rats that had received an intraperitoneal administration
of 1 or 5mg/kg of EECP (Figures 1(b) and 1(c)). Particularly,
the largest restoration occurred in the animals that had
received 1mg/kg of EECP, for which the value of the BBB
rating scale was signiﬁcantly higher than that of the vehicle-
treated group between experimental days 9 and 16.
3.2. Evaluation of mRNA Levels of iNOS and Neurotrophic
Factors in the Site of SCI. To assess the anti-inﬂammatory
eﬀect of EECP on the injured spinal cord, we ﬁrst examined
by RT-PCR the expression level of iNOS mRNA in the injury
siteinratsthathadreceiveddailyadministrationofvehicleor
EECP (1mg/kg). The expression of iNOS mRNA markedly
increased and attained its maximal level 1 day after SCI, and
gradually decreased to the original level irrespective of EECP
administration. The expression level of iNOS mRNA was
signiﬁcantly lower in the EECP-treated group than in the
vehicle-treated group, when evaluated 1 day or 3 days after
the SCI and subsequent EECP administration (Figure 2(a)).
Next, the mRNA levels of neurotrophic factors BDNF,
NT-3, and GDNF in the site of SCI were examined. Expres-
s i o no fB D N Fa n dG D N Fm R N A sw a se v o k e di nr e s p o n s e
to the injury, attained its maximal level on experimental
day 1, and rapidly decreased on experimental day 3 in both
vehicle- and EECP-treated groups (1mg/kg). Furthermore,
the BDNF mRNA of the vehicle-treated group decreased
to a level lower than that of the EECP-treated group on
experimental day 7, implying that EECP sustained the BDNF
mRNA level signiﬁcantly higher, which level would have
otherwise decreased at that time (Figure 2(b)). In contrast,
the expression of NT-3 mRNA was rather decreased in
response to the injury, attained its minimal level on exper-
imental day 3, and gradually recovered to the original level
in both groups. EECP limitedly but signiﬁcantly enhanced
the recovery of the decreased expression of NT-3 mRNA on
experimental day 7 (Figure 2(c)). EECP did not aﬀect the
expression of GDNF mRNA in the lesion site throughout the
experimental period (Figure 2(d)).
3.3. Decrease in Size of Spinal Cord Lesion after EECP Admin-
istration. To assess histologically the anti-inﬂammatory
eﬀect of EECP on the injured spinal cord, we measured
on experimental day 14 the size of the lesion site in the
spinal cord of rats that had received daily administration
of vehicle or EECP (1mg/kg). The EECP-treated animals
hadsigniﬁcantlysmallerlesionsthanthevehicle-treatedones
(Figure 3).
4. Discussion
In this study, we found that EECP (1) accelerated repair of
the SCI-induced locomotor function, (2) decreased the level
of iNOS mRNA in the lesion site of the spinal cord and
increasedthatofBDNFandNT-3mRNAs,and(3)decreased
the lesion size in the injured spinal cord of the rats.
In the CNS, NO is involved in a variety of biological
processes to maintain homeostasis; however, it also plays
a detrimental role as a potent oxidant during pathophys-
iological processes occurring in neural tissues [25]. Under
pathologicalcircumstances,excessiveNOismainlyproduced
by injury-activated iNOS, and causes apoptosis [32]. There-
fore, the strategy to reduce iNOS expression or suppress NO4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: EECP accelerated locomotor functional recovery after hemi-transection of the rat spinal cord. Changes in the locomotor function
of the vehicle-treated (n = 9) and EECP-treated animals (n = 7) during the 3-week experimental period are shown. EECP-treated group
(1mg/kg, (b) 5mg/kg, (c)) showed a signiﬁcant behavioral improvement compared with the vehicle-treated group. However, a low dose of
EECP (0.2mg/kg, (a)) had no eﬀect on the recovery of locomotor function after SCI. Signiﬁcance of diﬀerences from vehicle-treated group
was determined by using repeated measures of two-way ANOVA followed by the Bonferroni post-test. ∗P<. 05, ∗∗P<. 01, and ∗∗∗P<. 001
versus vehicle-treated group.
production in the lesion site can be a practical approach
to prevent or repair the injury-induced neuropathological
dysfunction. It is known that an ethanol extract of propolis
inhibits the gene expression and enzyme activity of iNOS
[33], which is at least partly responsible for the neuro-
protective activity aﬀorded by the components of propolis
[13, 15]. However, the eﬀect of the EECP on traumatic
SCI remained to be elucidated. Our present study clearly
demonstrated that the EECP attenuated the expression of
iNOS mRNA and reduced the lesion size in the injured
spinal cord (Figures 2 and 3), consistent with our previous
ﬁnding that pyrroloquinoline quinine, a naturally occurring
redox cofactor, improves locomotor function after SCI by
lowering iNOS gene expression [34]. It was earlier reported
that injury-induced NO is involved in the formation of the
cavity after damage to the spinal cord, which formation is
followed by loss of neurological function [26], suggesting
that the EECP lightened the secondary damage after SCI via
attenuation of iNOS gene expression. We consider the cells
predominantly expressing injury-evoked iNOS mRNA to
have been inﬂammatory cells such as macrophages invading
the damaged tissue; because the iNOS-expressing cells that
invaded the lesioned area were positive for ED-2, a marker of
macrophages and/or perivascular cells, and their populationEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: EECP attenuated the expression of iNOS mRNA and enhanced that of BDNF and NT-3 mRNAs in the site of SCI. Vehicle or
EECP (1mg/kg) was daily administered to rats with SCI. The results of RT-PCR analysis of various genes in the injured spinal cord of rats
that had received daily administration of vehicle or EECP are shown. (a) The expression level of iNOS mRNA in the injured spinal cord
was signiﬁcantly lower in the EECP-treated group (n = 3) than in the vehicle-treated group (n = 3) on experimental days 1 and 3. (b),
(c) and (d) mRNA expression levels of BDNF (b) and NT-3 (c) were signiﬁcantly higher in the EECP-treated group (n = 6) than in the
vehicle-treated group (n = 6) on experimental day 7, but there was no signiﬁcant diﬀerence in the GDNF (d) mRNA level between the 2
groups (n = 3). Signiﬁcance of diﬀerences from vehicle-treated group was determined by using two-way ANOVA followed by the Bonferroni
post-test. ∗P<. 05, ∗∗P<. 01 versus vehicle-treated group. β-Actin was used as the internal control.6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: EECP reduced the lesion size in the injured spinal cord.
Vehicle or EECP (1mg/kg) was daily administered to rats with SCI.
Fluorescence photographs of immunoreactivity of GFAP in the SCI
lesionsiteofthevehicle-treatedgroup(n = 3)(a))andinthatofthe
EECP-treated group (n = 3) (b)) are shown. The area surrounded
by the dashed line (lesion size, (a), (b)) was compared between the
EECP-treated and the vehicle-treated groups (c). The lesion size
of the EECP-treated group was signiﬁcantly smaller than that of
the vehicle-treated group on experimental day 14. The left side is
rostral. Signiﬁcance of diﬀerences from vehicle-treated group was
determined by using Student’s t-test. ∗∗P<. 01 versus vehicle-
treated group. Scale bar: (a), (b), 200μm.
peaked at 1 day and then declined, disappearing 3 days after
the injury [32], consistent with the time course of iNOS
mRNA expression in the injury site (Figure 2).
Our present study revealed that the EECP could modify
upwardly the injury-evoked mRNA expression of BDNF and
NT-3 on experimental day 7 (Figure 2). We propose that
upregulation of these neurotrophins contributed partly to
the restoration of the functional locomotor activity, because
neurotrophins such as BDNF and NT-3 delivered to the
injury site induce axonal sprouting and/or axonal regenera-
tionfollowedbyimprovementoflocomotoractivityafterSCI
[35,36].AsanotherproﬁtableeﬀectoftheEECPonneuronal
function, our preliminary results (Kasai et al., unpublished
data) suggest that the EECP activates the mitogen-activated
protein kinase (MAPK)/extracellular signal-regulated kinase
(ERK) 1/2 signaling pathway (ERK1/2) in cultured cortical
neurons. The ERK1/2 signaling pathway is preferentially
activated in response to extracellular stimuli, including
growth factors and neurotrophic factors [37]. For instance,
BDNF and NT-3 bind to high-aﬃnity tyrosine kinase recep-
tors, TrkB and TrkC, respectively, and activate the ERK1/2
signaling pathway to inﬂuence growth, development, diﬀer-
entiation, and survival of neurons [38]. Therefore, the EECP
may mimic at least partly the signaling pathway of BDNF
and/or NT-3, facilitating axonal regeneration in the injured
spinal cord. The EECP may thus facilitate improvement of
hindlimb locomotor function after SCI.
What components in the EECP are responsible for the
beneﬁcial eﬀect found in present study? Numerous studies,
carried out with the combined eﬀorts of phytochemists
and pharmacologists, have led in recent years to the idea
that diﬀerent propolis samples could be completely diﬀerent
in their chemistry and biological activity [4]. It has been
reported that Chinese propolis contains many biologically
active constituents expected to be useful for improvement
of the neuropathological conditions in the injured spinal
cord [28]. For example, CAPE is a constituent identiﬁed
to exert antiinﬂammatory activity through inhibiting the
gene expression and catalytic activity of iNOS [39], and
to protect the brain from ischemia-reperfusion injury [13].
Therefore, CAPE is one of the most probable candidates
that may act beneﬁcially after traumatic SCI. Chrysin, the
ﬂavonoid of highest concentration in Chinese propolis,
potentially represents anti-oxidative capacity in neuronal cell
death and exhibits an anti-inﬂammatory eﬀect by inhibiting
iNOS mRNA and NO production [40, 41]. Additionally,
pinocembrin, also one of the main ﬂavonoids in Chinese
propolis, exerts its neuroprotective eﬀect on oxygen-glucose
deprivation/reoxygenation-injured cortical neurons based
on a probable mechanism involving a reduction in iNOS
[15]. It is highly possible that these ﬂavonoids can reduce the
inﬂammatory and/or apoptotic circumstance induced after
SCI. Artepillin C, though a major component of Brazilian
propolis, induces neurite outgrowth from PC12m3 cells, a
celllineestablishedfromparentalPC12cells,viaERK1/2and
p38 MAPK pathways [20]. Thus, artepillin C might be a can-
didate to stimulate axonal regeneration in the injured spinal
cord. It is likely that the neurological outcomes observed in
our present study could have resulted from the biological
activities of plural constituents of propolis. Evaluation of the
eﬀective constituent(s) on locomotor functional recovery is
nowinprogressinourlaboratory.Furthermore,weareplan-
ning to search for unknown active components that possess
the potential to repair the SCI. For overcoming the critical
issue of variation in the quality of propolis preparations, the
biological properties of EECP from preparations of diﬀerent
chemical composition must be compared.
In summary, we demonstrated that the intraperitoneal
administration of EECP reduced the inﬂammation and/or
apoptosis through attenuating iNOS mRNA expression, butEvidence-Based Complementary and Alternative Medicine 7
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Figure 4: Hypothetical diagram showing mechanism of the eﬀect of EECP on spinal cord neurotrauma. EECP attenuates the expression
iNOS mRNA, probably derived from macrophages that have inﬁltrated into the lesioned area. Furthermore, EECP increases BDNF and
NT-3 gene expression in the injured spinal cord, which may protect neurons and myelin (elaborated by oligodendrocytes) and/or cause
regeneration of the transected axons. These eﬀects of EECP may partially contribute to the decreased lesion area and improved locomotor
function after SCI.
increased BDNF and NT-3 mRNA expression, in the injured
spinal cord. These changes resulted in the reduced lesion
size and improved locomotor function after SCI (Figure 4).
Although identiﬁcation of the active constituents of the
EECP, elucidation of the critical action mechanisms, and
evaluation to decide the validity of administering EECP by
oral administration still remain to be resolved, propolis and
its active constituents may be developed in the future as
evidence-based complementary and alternative medicines
a n db ee x p e c t e da sp r o m i s i n gt o o l sf o rt h et r e a t m e n to fS C I .
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